J. Roh

发表

Molecular biomarkers in non-small-cell lung cancer: a retrospective analysis of data from the phase 3 FLEX study.

K. O'Byrne, R. Ramlau, J. von Pawel, 2011, The Lancet. Oncology.

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer.

E. Van Cutsem, G. D'Haens, R. Lim, 2009, The New England journal of medicine.

Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial

Robert Pirker, K. O'Byrne, Keunchil Park, 2009, The Lancet.

Advanced detection of recent changing trends in gastric cancer survival: up-to-date comparison by period analysis.

Hyo Song Kim, J. Roh, Hyunkyoung Lee, 2011, Japanese journal of clinical oncology.

Hormonal Anticancer Drugs

J. Roh, H. Wee, Kyu-Won Kim, 2016 .

Two Dosages of Oral Fluoropyrimidine S-1 of 35 and 40 mg/m2 bid: Comparison of the Pharmacokinetic Profiles in Korean Patients with Advanced Gastric Cancer

J. Roh, H. Chung, S. Noh, 2009, Japanese journal of clinical oncology.

Thymidine phosphorylase suppresses apoptosis induced by microtubule-interfering agents.

J. Roh, T. Furukawa, S. Akiyama, 2005, Biochemical pharmacology.

Protection against DNA damage‐induced apoptosis by the angiogenic factor thymidine phosphorylase

J. Roh, T. Furukawa, S. Akiyama, 2006, FEBS letters.

A phase I clinical trial and pharmacokinetic evaluation of liposome-encapsulated doxorubicin.

W. Alvord, P. Woolley, J. Roh, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Oncologic Outcomes After Neoadjuvant Chemoradiation Followed by Curative Resection With Tumor-Specific Mesorectal Excision for Fixed Locally Advanced Rectal Cancer: Impact of Postirradiated Pathologic Downstaging on Local Recurrence and Survival

Hoguen Kim, J. Roh, J. Seong, 2006, Annals of surgery.

A Randomized Phase 2 Study of Neoadjuvant Chemoradiaton Therapy With 5-Fluorouracil/Leucovorin or Irinotecan/S-1 in Patients With Locally Advanced Rectal Cancer.

J. Lim, Hoguen Kim, J. Roh, 2015, International journal of radiation oncology, biology, physics.

Alkylating Anticancer Drugs

J. Roh, H. Wee, Kyu-Won Kim, 2016 .

Cetuximab in Combination with 5-Fluorouracil, Leucovorin and Irinotecan as a Neoadjuvant Chemotherapy in Patients with Initially Unresectable Colorectal Liver Metastases

J. Roh, N. Kim, B. Min, 2007, Oncology Research and Treatment.

Randomized controlled trial of standardized education and telemonitoring for pain in outpatients with advanced solid tumors

Hyo Song Kim, J. Roh, B. Cho, 2013, Supportive Care in Cancer.

Mobilized CD34+ cells as a biomarker candidate for the efficacy of combined maximal tolerance dose and continuous infusional chemotherapy and G-CSF surge in gastric cancer.

J. Roh, H. Chung, S. Noh, 2008, Cancer letters.

Prognostic factors affecting oncologic outcomes in patients with locally recurrent rectal cancer: impact of patterns of pelvic recurrence on curative resection

J. Roh, K. Keum, Y. Choi, 2008, Langenbeck's archives of surgery (Print).

Estimating the adjuvant chemotherapy effect in elderly stage II and III colon cancer patients in an observational study

I. Cha, J. Roh, N. Kim, 2013, Journal of surgical oncology.

A Randomized Phase II/III Study of Dalotuzumab in Combination With Cetuximab and Irinotecan in Chemorefractory, KRAS Wild-Type, Metastatic Colorectal Cancer.

M. Ayers, J. Tabernero, Tae Won Kim, 2015, Journal of the National Cancer Institute.

Changing treatment patterns in elderly patients with resectable colon cancer

J. Roh, H. Chung, S. Rha, 2013, Asia-Pacific journal of clinical oncology.

O-0024 Phase 2 Randomized, Noncomparative, Open-Label Study of Aflibercept and Modified Folfox6 in the First-Line Treatment of Metastatic Colorectal Cancer (AFFIRM)

J. Roh, J. Zalcberg, G. Folprecht, 2012 .

Curative Resection Following Neoadjuvant Chemotherapy Including a Molecularly Targeted Agent in Patients with Unresectable Colorectal Distant Metastases

J. Roh, N. Kim, H. Hur, 2008 .

A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy

Tae Won Kim, J. Roh, H. Chung, 2012, Investigational New Drugs.

Implications of clinical risk score to predict outcomes of liver-confined metastasis of colorectal cancer.

J. Roh, N. Kim, H. Hur, 2012, Surgical oncology.

Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study.

J. Roh, J. Zalcberg, G. Folprecht, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II trial of S-1 monotherapy in elderly or frail patients with metastatic colorectal cancer

Myung Ah Lee, Tae Won Kim, J. Roh, 2011, Investigational New Drugs.

The combination of capecitabine and irinotecan in treating 5-Fluorouracil- and Oxaliplatin-pretreated metastatic colorectal cancer

J. Roh, B. Cho, H. Chung, 2007, Cancer Chemotherapy and Pharmacology.

A phase I pharmacokinetic study of TSU-68 (a multiple tyrosine kinase inhibitor of VEGFR-2, FGF and PDFG) in combination with S-1 and oxaliplatin in metastatic colorectal cancer patients previously treated with chemotherapy

J. Roh, H. Chung, S. Rha, 2012, Investigational New Drugs.

Monthly 5-days 5-fluorouracil and low-dose leucovorin for adjuvant chemotherapy in colon cancer.

J. Roh, S. Rha, J. Min, 2001, Cancer letters.

Association of Depression and Survival in Patients with Cancer over 10 Years

J. Roh, Suk-Jeong Lee, Joohyung Kim, 2015 .

Union for International Cancer Control International Session: Healthcare Economics: The significance of the UN summit non‐communicable diseases political declaration in Asia

T. Masui, H. Akaza, J. Roh, 2013, Cancer science.

Clinicopathologic Features of Metachronous or Synchronous Gastric Cancer Patients with Three or More Primary Sites

Joo Hoon Kim, Hyo Song Kim, J. Roh, 2010, Cancer research and treatment : official journal of Korean Cancer Association.

Outcomes of multiple salvage chemotherapy for advanced gastric cancer: implications for clinical practice and trial design

J. Roh, H. Chung, S. Noh, 2010, Cancer Chemotherapy and Pharmacology.

Weekly Gemcitabine and Docetaxel in Refractory Soft Tissue Sarcoma: A Retrospective Analysis

Hyo Song Kim, J. Roh, J. Han, 2012, Cancer research and treatment : official journal of Korean Cancer Association.

Predictive values of 5-fluorouracil pathway genes for S-1 treatment in patients with advanced gastric cancer

J. Roh, H. Chung, S. Noh, 2011, Anti-cancer drugs.

A Phase II Study of a Combined Biweekly Irinotecan and Monthly Cisplatin Treatment for Metastatic or Recurrent Gastric Cancer

J. Roh, H. Chung, S. Noh, 2010, American journal of clinical oncology.

Clinical features and treatment outcomes of advanced stage primary hepatic angiosarcoma.

Y. N. Park, J. Roh, S. Rha, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Paclitaxel combined with ifosfamide in anthracycline- and docetaxel-pretreated metastatic breast cancer: activity independence of prior docetaxel resistance

Seho Park, Seung Il Kim, Byeong‐Woo Park, 2010, Cancer Chemotherapy and Pharmacology.

A Phase II Feasibility Study of Weekly Paclitaxel in Heavily Pretreated Advanced Gastric Cancer Patients with Poor Performance Status

J. Roh, Soo Hyeon Lee, H. Chung, 2009, Oncology.

Prognostic implications of anaplastic lymphoma kinase gene aberrations in rhabdomyosarcoma; an immunohistochemical and fluorescence in situ hybridisation study

Se Hoon Kim, K. Shin, Hyo Song Kim, 2013, Journal of Clinical Pathology.

Correlation between K‐ras gene mutation and prognosis of patients with nonsmall cell lung carcinoma

J. Roh, Joo‐Hang Kim, H. Chung, 1997, Cancer.

Transduction effect of antisense K-ras on malignant phenotypes in gastric cancer cells.

J. Roh, E. Kim, Y. Kim, 2000, Cancer letters.

Leiomyosarcoma: investigation of prognostic factors for risk-stratification model

Young Han Lee, Hyo Song Kim, J. Roh, 2015, International Journal of Clinical Oncology.

Capecitabine and doxorubicin combination chemotherapy as salvage therapy in pretreated advanced gastric cancer

J. Roh, B. Cho, H. Chung, 2007, Cancer Chemotherapy and Pharmacology.

Phase II study of combination chemotherapy of 5-fluorouracil, low-dose leucovorin, and oxaliplatin (FLOX regimen) in pretreated advanced gastric cancer.

J. Roh, S. Shin, S. Noh, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Clinical relevance of three subtypes of primary sinonasal lymphoma characterized by immunophenotypic analysis

Sang‐wook Lee, J. Roh, K. Keum, 2004, Head & neck.

Angiocentric T-cell and NK/T-cell lymphomas: radiotherapeutic viewpoints.

J. Roh, E. Chung, W. Koom, 2004, International journal of radiation oncology, biology, physics.

Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment.

J. Roh, E. Chung, C. Suh, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Joint Symposium of Korean Cancer Association & UICC-ARO-Cross-boundary cancer studies: cancer and Universal Health Coverage (UHC) in Asia.

H. Akaza, J. Roh, E. Park, 2017, Japanese journal of clinical oncology.

Clinical significance of margin status in postoperative radiotherapy for extremity and truncal soft-tissue sarcoma.

K. Shin, J. Roh, C. Suh, 2008, International journal of radiation oncology, biology, physics.

Association of the ABCB1 gene polymorphisms 2677G>T/A and 3435C>T with clinical outcomes of paclitaxel monotherapy in metastatic breast cancer patients.

J. Roh, S. Rha, H. Chung, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Association of the ABCB 1 gene polymorphisms 2677 G > T / A and 3435 C > T with clinical outcomes of paclitaxel monotherapy in metastatic breast cancer patients

J. Roh, S. Rha, H. Chung, 2009 .

Postoperative adjuvant chemotherapy of gastric cancer: scrutiny into the clinical evidence based on quality assessment of medical literature of randomized controlled trials

J. Roh, H. Chung, S. Noh, 2009, Cancer Chemotherapy and Pharmacology.

Antimetabolic Anticancer Drugs

J. Roh, H. Wee, Kyu-Won Kim, 2016 .

Circulating endothelial progenitor cells (EPC) for tumor vasculogenesis in gastric cancer patients.

J. Roh, H. Chung, S. Noh, 2010, Cancer letters.

Combined use of tamoxifen, cyclosporin A, and verapamil for modulating multidrug resistance in human hepatocellular carcinoma cell lines.

J. Roh, O. Kwon, Byung Soo Kim, 1993, Yonsei medical journal.

Perioperative blood transfusions and prognosis in patients with curatively resected locally advanced gastric cancer.

J. Roh, J. Min, H. Chung, 1995, Oncology.

Treatment of Hodgkin's Disease: A Twenty-Year Follow-up of Patients at a Center in Korea

J. Roh, C. Suh, J. Cheong, 2006, Yonsei medical journal.

Glyphosate influences cell proliferation in vitro

J. Roh, Jang-Eok Kim, Heeyoun Bunch, 2019 .

Epidemiologic and Clinical Characteristics of Migraine and Tension‐Type Headache in Korea

J. Roh, J. Roh, J. Kim, 1998, Headache.

Adjuvant treatment of operable stomach cancer with polyadenylic.polyuridylic acid in addition to chemotherapeutic agents: a preliminary report.

J. Roh, I. Park, J. Min, 1990, International journal of immunopharmacology.

Fractional weekly administration of irinotecan and cisplatin as a second-line treatment for advanced gastric cancer

J. Roh, H. Chung, S. Noh, 2005 .

Angiocentric L ymphoma o f t he H ead a nd N eck: P atterns o f Systemic F ailure A fter R adiation T reatment

J. Roh, E. Chung, C. Suh, 2000 .

A phase II study of S-1 monotherapy administered for 2 weeks of a 3-week cycle in advanced gastric cancer patients with poor performance status

J. Roh, S. Shin, S. Noh, 2007, British Journal of Cancer.

Natural Product Anticancer Drugs

J. Roh, H. Wee, Kyu-Won Kim, 2016 .

Physiological and pathological changes of plasma urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor levels in healthy females and breast cancer patients

Joon-Oh Park, J. Roh, H. Chung, 1998, Breast Cancer Research and Treatment.

3001 ORAL CRYSTAL, a randomized phase III trial of cetuximab plus FOLFIRI vs. FOLFIRI in first-line metastatic colorectal cancer (mCRC)

P. Lebrun, F. Ciardiello, J. Roh, 2007 .

Phase III study comparing cisplatin/vinorelbine plus cetuximab versus cisplatin/vinorelbine as first-line treatment for patients with epidermal growth factor (EGFR)-expressing advanced non-small cell lung cancer (NSCLC) (FLEX).

M. Krzakowski, J. von Pawel, J. R. Pereira, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Salvage chemotherapy of biweekly irinotecan plus S-1 (biweekly IRIS) in previously treated patients with advanced gastric cancer

Hyo Song Kim, J. Roh, H. Chung, 2011, Cancer Chemotherapy and Pharmacology.

Modulation of biological phenotypes for tumor growth and metastasis by target-specific biological inhibitors in gastric cancer.

J. Roh, S. Noh, S. Rha, 1999, International journal of molecular medicine.

Associations between Depression, Anxiety, Hostility and Fighting Spirit among Cancer Patients in a Cancer Center in Korea.

J. Roh, Suk-Jeong Lee, Joohyung Kim, 2003, Cancer research and treatment : official journal of Korean Cancer Association.

Gemcitabine monotherapy as salvage chemotherapy in heavily pretreated metastatic breast cancer

J. Roh, C. Suh, G. Kim, 2005, Breast Cancer Research and Treatment.

A phase II study of paclitaxel combined with infusional 5-fluorouracil and low-dose leucovorin for advanced gastric cancer

J. Roh, H. Chung, S. Noh, 2007, Cancer Chemotherapy and Pharmacology.

Lack of Correlation Between P-glycoprotein and Chemotherapy Resistance in Nasal NK/T-cell Lymphomas

Sang‐wook Lee, J. Roh, C. Suh, 2004, Leukemia & lymphoma.

Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases.

J. Roh, S. Noh, S. Rha, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Relationship between p53 overexpression and gastric cancer progression.

D. Shin, J. Roh, S. Noh, 1997, Oncology.

An association between RRM1 haplotype and gemcitabine-induced neutropenia in breast cancer patients.

J. Roh, W. Yang, H. Chung, 2007, The oncologist.

Comparative nephrotoxicity of tetraplatin and cisplatin in rats.

J. Roh, A. Rahman, H. Preuss, 1993, Nephron.

A Pilot Study of Trans-Arterial Injection of 166Holmium-Chitosan Complex for Treatment of Small Hepatocellular Carcinoma

J. Lee, J. Roh, B. Cho, 2005, Yonsei medical journal.

Adeno-associated virus mediated endostatin gene therapy in combination with topoisomerase inhibitor effectively controls liver tumor in mouse model.

S. Choi, J. Roh, Kyung-sup Kim, 2004, World journal of gastroenterology.

A phase I pharmacokinetic and pharmacodynamic study of CKD-732, an antiangiogenic agent, in patients with refractory solid cancer

J. Roh, H. Chung, S. Rha, 2010, Investigational New Drugs.

Vascular Soft-Tissue Sarcomas: A Prognostic Model from a Retrospective Single-Center Study

Young Han Lee, Hyo Song Kim, J. Roh, 2014, Oncology.

Changing Patterns of Prognosticators During 15-Year Follow-Up of Advanced Gastric Cancer after Radical Gastrectomy and Adjuvant Chemotherapy: A 15-Year Follow-Up Study at a Single Korean Institute

J. Roh, H. Chung, S. Noh, 2007, Annals of Surgical Oncology.

Genome-wide molecular characterization of mucinous colorectal adenocarcinoma using cDNA microarray analysis.

Woo Ick Yang, Hyun Cheol Chung, Sun Young Rha, 2011, Oncology reports.

Neoadjuvant chemotherapy and radiation for inoperable carcinoma of the maxillary antrum: a matched-control study.

J. Roh, K. Keum, E. Choi, 2000, American journal of clinical oncology.

Prognostic Value of Mucinous Histology Depends on Microsatellite Instability Status in Patients with Stage III Colon Cancer Treated with Adjuvant FOLFOX Chemotherapy: A Retrospective Cohort Study

Hyuk Hur, J. Roh, N. Kim, 2013, Annals of Surgical Oncology.

A randomized phase 2 study of docetaxel and S‐1 versus docetaxel and cisplatin in advanced gastric cancer with an evaluation of SPARC expression for personalized therapy

Woo Ick Yang, Hyun Cheol Chung, Sun Young Rha, 2011, Cancer.

Phase III trial of adjuvant 5-fluorouracil and adriamycin versus 5-fluorouracil, adriamycin, and polyadenylic-polyuridylic acid (poly A:U) for locally advanced gastric cancer after curative surgery: final results of 15-year follow-up.

J. Roh, S. Noh, S. Rha, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

p16 Hypermethylation and KRAS Mutation Are Independent Predictors of Cetuximab Plus FOLFIRI Chemotherapy in Patients with Metastatic Colorectal Cancer

J. Roh, N. Kim, K. Lee, 2015, Cancer research and treatment : official journal of Korean Cancer Association.

Irofulven as first line therapy in recurrent or metastatic gastric cancer: a phase II multicenter study by the Cancer Therapeutics Research Group (CTRG)

P. Beale, B. Goh, S. Clarke, 2006, Cancer Chemotherapy and Pharmacology.

Combination of CYP inhibitor with MEK/ERK inhibitor enhances the inhibitory effect on ERK in BRAF mutant colon cancer cells.

J. Roh, S. Lim, J. Hwang, 2013, Anticancer research.

Molecular Targeted Anticancer Drugs

J. Roh, H. Wee, Kyu-Won Kim, 2016 .

Cancer Drug Discovery

J. Roh, H. Wee, Kyu-Won Kim, 2016, Springer Netherlands.

Dalotuzumab in chemorefractory KRAS exon 2 mutant colorectal cancer: Results from a randomised phase II/III trial

M. Ayers, J. Tabernero, Tae Won Kim, 2017, International journal of cancer.

Chemokine growth‐regulated oncogene 1 as a putative biomarker for gastric cancer progression

J. Roh, Jaejoon Jung, H. Chung, 2010, Cancer science.

Telomerase activity and telomere lengths in various cell lines: changes of telomerase activity can be another method for chemosensitivity evaluation.

J. Roh, S. Noh, S. Rha, 1998, International journal of oncology.

Rapid prenatal diagnosis for chromosomal aneuploidy using cDNA microarray-based comparative genomic hybridization

J. Roh, S. Rha, Chan Park, 2005 .

Retrospective comparison of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (modified FAM) combination chemotherapy versus palliative therapy in treatment of advanced gastric cancer.

J. Roh, C. Kim, S. Noh, 1997, American journal of clinical oncology.

Changes in telomerase activity due to alternative splicing of human telomerase reverse transcriptase in colorectal cancer.

J. Roh, H. Chung, S. Rha, 2017, Oncology letters.

Advancement of the Science and History of Cancer and Anticancer Drugs

J. Roh, H. Wee, Kyu-Won Kim, 2016 .

Immunotherapeutic Anticancer Drugs and Other Miscellaneous Anticancer Drugs

J. Roh, H. Wee, Kyu-Won Kim, 2016 .

Occurrence of p53 gene abnormalities in gastric carcinoma tumors and cell lines.

J. Minna, A. Gazdar, J. Roh, 1991, Journal of the National Cancer Institute.

Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: a multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group.

B. Goh, W. Yeo, Q. Tao, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Advancements in Life Sciences and Characteristic Features of Cancer Cells

J. Roh, H. Wee, Kyu-Won Kim, 2016 .

Molecular analysis of the randomized phase II/III study of the anti-IGF-1R antibody dalotuzumab (MK-0646) in combination with cetuximab (Cx) and irinotecan (Ir) in the treatment of chemorefractory KRAS wild-type metastatic colorectal cancer (mCRC)

J. Lunceford, M. Ayers, E. Schmidt, 2012 .

High level of urokinase‐type plasminogen activator is a new prognostic marker in patients with gastric carcinoma

J. Roh, H. Chung, S. Noh, 1997, Cancer.

Synchronous elevation of soluble intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) correlates with gastric cancer progression.

J. Roh, S. Noh, S. Rha, 1998, Yonsei medical journal.

Correlation of tissue and blood plasminogen activation system in breast cancer.

J. J. Kim, J. Roh, S. Rha, 2000, Cancer letters.

Application of the Western-based adjuvant online model to Korean colon cancer patients; a single institution experience

J. Roh, N. Kim, H. Chung, 2012, BMC Cancer.

Comparison of Long-Term Outcome between Doublet and Triplet Neoadjuvant Chemotherapy in Non-Metastatic Osteosarcoma of the Extremity

J. Roh, S. Rha, S. Shin, 2011, Oncology.

Bilateral breast cancer: differential diagnosis using histological and biological parameters.

J. Roh, W. Yang, H. Chung, 2007, Japanese journal of clinical oncology.

Infusional 5-Fluorouracil, Leucovorin and Docetaxel in Advanced Gastric Cancer.

J. Roh, So Hun Kim, H. Chung, 2003, Cancer research and treatment : official journal of Korean Cancer Association.

A comparative study of intravenous granisetron versus intravenous and oral ondansetron in the prevention of nausea and vomiting associated with moderately emetogenic chemotherapy.

J. Roh, S. Rha, J. Min, 1997, American journal of clinical oncology.

Therapeutic and pharmacological studies of tetrachloro(d,l-trans)1,2-diaminocyclohexane platinum (IV) (tetraplatin), a new platinum analogue.

A. Goldin, J. Venditti, P. Woolley, 1988, Cancer research.

Chemoradiotherapy with or without consolidation chemotherapy using cisplatin and 5-fluorouracil in anal squamous cell carcinoma: long-term results in 31 patients

J. Roh, B. Cho, J. Seong, 2008, BMC Cancer.

Brain metastases from colorectal carcinoma: prognostic factors and outcome

Jong-Hee Chang, J. Roh, C. Suh, 2010, Journal of Neuro-Oncology.

Comparative pharmacokinetics of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes.

J. Roh, A. Rahman, D. Carmichael, 1986, Cancer research.

An unusual case of gastric carcinoma with synchronous non-Hodgkin's lymphoma.

J. Roh, S. H. Park, S. Noh, 1998, Yonsei medical journal.

A case of paraneoplastic nephrotic syndrome in a patient with ovarian carcinoma.

J. Roh, H. Chung, S. Rha, 2003, Yonsei medical journal.

Comparison of biological phenotypes according to midkine expression in gastric cancer cells and their autocrine activities could be modulated by pentosan polysulfate.

A. Wellstein, J. Roh, H. Kwak, 1997, Cancer letters.

Circulating vascular endothelial growth factor receptor 2/pAkt-positive cells as a functional pharmacodynamic marker in metastatic colorectal cancers treated with antiangiogenic agent

J. Roh, J. Hwang, H. Chung, 2013, Investigational New Drugs.

Early Postoperative Intraperitoneal Chemotherapy with Mitomycin C, 5-Fluorouracil and Cisplatin for Advanced Gastric Cancer

J. Roh, H. Chung, S. Noh, 2000, Oncology.

A Phase II Study of Infusional 5-Fluorouracil and Low-Dose Leucovorin with Docetaxel for Advanced Gastric Cancer

J. Roh, H. Chung, S. Noh, 2006, Oncology.

An Association Between RRM 1 Haplotype and Gemcitabine-Induced Neutropenia in Breast Cancer Patients

J. Roh, W. Yang, S. Rha, 2007 .

Gastric cancer in young patients who underwent curative resection. Comparative study with older patients.

J. Roh, J. Min, H. Chung, 1996, American journal of clinical oncology.

Changes of telomerase and telomere lengths in paired normal and cancer tissues of breast.

J. Roh, S. Rha, J. Min, 1999, International journal of oncology.

P-glycoprotein: The intermediate end point of drug response to induction chemotherapy in locally advanced breast cancer

J. Roh, H. Chung, S. Rha, 2004, Breast Cancer Research and Treatment.

A Case Report of Primary Cardiac Lymphoma: Diagnosis by Transvenous Biopsy

Hyuk-Jae Chang, Y. Jang, S. Cho, 1999 .

Intravenous 5-fluorouracil versus oral doxifluridine as preoperative concurrent chemoradiation for locally advanced rectal cancer: prospective randomized trials.

S. Yun, J. Roh, J. Min, 2001, Japanese journal of clinical oncology.

Roundtable discussion at the UICC World Cancer Congress: looking toward the realization of universal health coverage for cancer in Asia.

E. Trimble, H. Akaza, J. Roh, 2015, Asian Pacific journal of cancer prevention : APJCP.

Application of the Adjuvant! Online Model to Korean Breast Cancer Patients: An Assessment of Prognostic Accuracy and Development of an Alternative Prognostic Tool

J. Roh, C. Nam, W. Yang, 2013, Annals of Surgical Oncology.

Long-term Survival after Surgical Resection for Liver Metastasis from G astric Cancer : Two Case Reports

J. Roh, H. Chung, S. Noh, 2009 .

Long-term survival after surgical resection for liver metastasis from gastric cancer: two case reports.

J. Roh, H. Chung, S. Noh, 2006, Cancer research and treatment : official journal of Korean Cancer Association.

The Clinical Outcome of Chemotherapy-Induced Amenorrhea in Premenopausal Young Patients with Breast Cancer with Long-Term Follow-up

J. Roh, W. Yang, H. Chung, 2010, Annals of Surgical Oncology.

Breast Oncology The Clinical Outcome of Chemotherapy-Induced Amenorrhea in Premenopausal Young Patients with Breast Cancer with Long-Term Follow-up

J. Roh, W. Yang, H. Chung, 2010 .

Adenocarcinoma of the small bowel at a single Korean institute: management and prognosticators

J. Roh, H. Shim, S. Rha, 2010, Journal of Cancer Research and Clinical Oncology.

A phase II trial of weekly fractionated irinotecan and cisplatin for advanced gastric cancer

J. Roh, H. Chung, S. Noh, 2006, Cancer Chemotherapy and Pharmacology.

Tissue urokinase-type plasminogen activator receptor levels in breast cancer.

J. Roh, S. Rha, J. Min, 2000, International journal of molecular medicine.

Efficacy of postoperative concurrent chemoradiation for resectable rectal cancer: a single institute experience.

J. Roh, C. Suh, G. Kim, 2004, Cancer research and treatment : official journal of Korean Cancer Association.

Clinical value of ezrin expression in primary osteosarcoma.

J. Roh, W. Yang, S. Rha, 2009, Cancer research and treatment : official journal of Korean Cancer Association.

Effects of interleukin-2 transduction on the human hepatoma cell lines using retroviral vector.

S. Jeong, J. Roh, D. Shin, 1999, Oncology reports.

Efficacy of Pre- and Postoperative Chemotherapy in Patients with Osteosarcoma of the Extremities.

K. Shin, J. Roh, W. Yang, 2001, Cancer research and treatment : official journal of Korean Cancer Association.

UICC International Session: What are the implications of sharing the concept of Universal Health Coverage for cancer in Asia?

H. Akaza, J. Roh, E. Park, 2016, Cancer science.

Japanese Cancer Association Meeting UICC International session--what is cost-effectiveness in cancer treatment?

H. Akaza, J. Roh, E. Park, 2014, Asian Pacific journal of cancer prevention : APJCP.

A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens

J. Roh, B. Cho, S. Rha, 2006, British Journal of Cancer.

Phase II study of preoperative chemoradiotherapy (CRT) with irinotecan plus S-1 in locally advanced rectal cancer.

J. Roh, K. Keum, N. Kim, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Chronology of Anticancer Drug Development

J. Roh, H. Wee, Kyu-Won Kim, 2016 .

Symposium: “Oncology Leadership in Asia”

Kazuhiro Yoshida, D. Noh, Z. Aziz, 2017, Cancer research and treatment : official journal of Korean Cancer Association.

A Carcinoembryonic Antigen-Secreting Adenocarcinoma Arising in Tailgut Cyst : Clinical Implications of Carcinoembryonic Antigen

J. Roh, B. Cho, S. E. Park, 2005, Yonsei medical journal.

A Prospective, Multicenter, Phase 2 Study of Imatinib Mesylate in Korean Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumor

Joon-Oh Park, D. Shin, Y. Bang, 2009, Oncology.

Copy number changes can be a predictor for hemoglobin reduction after S-1 monotherapy in gastric cancer.

J. Roh, H. Chung, S. Noh, 2009, International journal of oncology.

Different expression patterns of MMP-2 and MMP-9 in breast cancer.

J. Roh, W. Yang, S. Rha, 1998, Oncology reports.

Changing trends in histologic types of lung cancer during the last decade (1981-1990) in Korea: a hospital-based study.

J. Roh, Jin-Hyuk Choi, Sung Kyu Kim, 1994, Lung cancer.

Male breast cancer--a 20-year review of 16 cases at Yonsei University.

J. Roh, C. Suh, J. Min, 1990, Yonsei medical journal.

The role of radiation treatment in management of extrahepatic biliary tract metastasis from gastric carcinoma.

J. Roh, C. Suh, B. Kim, 1994, International journal of radiation oncology, biology, physics.

Phase I trial of neoadjuvant concurrent chemoradiotherapy with S-1 and weekly irinotecan in locally advanced rectal cancer.

J. Roh, K. Keum, N. Kim, 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Menstrual state should be considered in determining sero-positivity of soluble angiogenic factors in breast cancer.

J. J. Kim, J. Roh, S. Rha, 1998, International Journal of Molecular Medicine.

The value of immunohistochemical detection of P-glycoprotein in breast cancer before and after induction chemotherapy.

J. Roh, J. Min, H. Chung, 1992, Yonsei medical journal.

A Randomized Phase II/III Study of Dalotuzumab in Combination With Cetuximab and Irinotecan in Chemorefractory, KRAS Wild-Type, Metastatic Colorectal Cancer.

M. Ayers, J. Tabernero, A. Loboda, 2015, Journal of the National Cancer Institute.

Complications of Anticancer Drugs and Their Management

J. Roh, Kyu-Won Kim, C. Kim, 2016 .

A Phase II Feasibility Study of Weekly Paclitaxel in Heavily Pretreated Advanced Gastric Cancer Patients with Poor Performance Status

J. Roh, Soo Hyeon Lee, H. Chung, 2009, Oncology.

Novel Methods for Clinical Risk Stratification in Patients with Colorectal Liver Metastases

I. Cha, J. Roh, N. Kim, 2014, Cancer research and treatment : official journal of Korean Cancer Association.